Singular Genomics Systems

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

To empower life science research using innovative technologies and ideas by enabling our global customers to make more informed decisions, more quickly.

To become the world’s leading provider of innovative life science tools that enable researchers to make more informed decisions, more quickly.

Singular Genomics has been selected for the Stanford Entrepreneur Challenge Semifinals in 2012 and 2013, and won the grand prize in 2013. We have also received grants from the National Institutes of Health and National Science Foundation.